Partnership evolution includes strategic integration of select Novo Nordisk technologies into Aspect Biosystems. Aspect will lead development, manufacturing and commercialisation, and Novo Nordisk will have defined rights to expand its… Read More
FRANKLIN LAKES, NJ – BD, a leading global medical technology company, will present its latest drug delivery innovations at Pharmapack 2026, Europe’s leading drug delivery event, taking place January 21–22,… Read More
CAPLYTA® nearly doubled the likelihood of remission at six weeks compared to placebo as an adjunctive therapy to an antidepressant based on pooled data from two Phase 3 studies. 65%… Read More
VANCOUVER, BC – Eyam Health and iiDiagnostics (iiDX), a company formed by the Infection Innovation Consortium: iiCON, have launched a collaboration to bring forward Eyam Health’s novel vaccine technology using advanced… Read More
FRANKLIN LAKES, N.J. – BD , a leading global medical technology company, announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the EnCor EnCompass™ Breast… Read More
